# Mastopexy Market

> Mastopexy Market Research Report By Tissue Incision (Skin, Adipose, Glandular), Technique (Anchor Pattern, Inverted-T Incision, Lollipop Pattern), Application (Sagging & Augmented Breasts), End Users (Hospitals & Clinics) - Global Forecast till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.22%
- **2024:** $ 1.26 Billion
- **2025:** $ 1.33 Billion
- **2035:** $ 2.21 Billion
- **Key Players:** Allergan (US), Mentor Worldwide (US), Sientra (US), Galderma (CH), Hugel (KR), Ipsen (FR), Revance Therapeutics (US), Medytox (KR)

**Report ID:** MRFR/MED/3880-HCR · **Pages:** 90 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/mastopexy-market-5323

---

## Market Summary

## **Global Mastopexy Market Overview**

Mastopexy Market Size was valued at USD 1.2 Billion in 2023. The Global Mastopexy industry is projected to grow from USD 1.3 Billion in 2024 to USD 1.9 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.20% during the forecast period (2024 - 2032).Mastopexy is a plastic surgery mammoplasty procedure for raising the sagging breasts by removing excess skin and tightening the surrounding tissues to reshape and support the new breast contour. 

A woman's breasts changes over time and becomes susceptible to ptosis or sagging due to aging, weight fluctuations, breastfeeding and pregnancy. Factors such as growing female geriatric population and increasing demands for aesthetic procedures are the major drivers for the market growth during the forecast period. According to the United Census Bureau, the global-female-geriatric population is estimated to reach 4,139 million by 2030 from 3,601 million as recorded in 2015. Moreover, increasing healthcare expenditures along with the growing demands for outpatient surgeries is boosting the market growth.

However, factors such as high cost along with the complications of extrusion, seroma, and scarring associated with surgery are projected to restrain the market growth.

**On 9 January 2024,** Dr. Dana Coberly, a plastic surgeon based in Tampa and certified by the board, released an article discussing the benefits of breast lifts. According to a report published in December 2011, it can increase cup size, reshape or lift sagging breasts, tighten up skin around one’s body and more.

The American Society of Plastic Surgeons (ASPS) collaborated with The Plastic Surgery Foundation (PSF) to announce October 19th as the eleventh annual Breast Reconstruction Awareness Day on Tuesday, October 11th, 2022. Many women who have mastopexy, mastectomy or lumpectomy do not know about the various breast reconstruction options that exist. Realizing that patients need accurate information upon which to base their choices regarding their care, ACLP and PSF created the Breast Reconstruction Awareness Campaign and BRS Day USA, respectively, calling for awareness and giving patients true facts about breastwork.

CollPlant announced in June 2022 that it had launched a study involving large animals for its regenerative breast implant program printed by 3D bioprinting techniques aimed at addressing worldwide market needs.

GC Aesthetics made headlines in May 2022 with their innovative Nipple Areola Complex (NAC) reconstruction implant. This medical device fulfilled the global clinical requirements of women.

Galderma obtained clearance from the United States Food and Drug Administration for RESTYLANE DEFYNE to augment and correct mild to moderate chin retrusion in adults in February 2022.

An example of this is in May 2021 when GC Aesthetics Incorporated introduced PERLE's brand new generation of breast implants. These smooth implants have proprietary surface technology and gel technology that is industry leading for GCA-based products and improved safety system built up over time giving GCA’s excellent long-term safety record.

Galderma was granted approval for RESTYLANE DEFYNE by the United States Food and Drug Administration (FDA) for augmentation and correction of mild to moderate chin retrusion among adults on February 12th, 2021.

## **Mastopexy Market Segment Insights**

The mastopexy market is segmented on the basis of tissue incision, technique, application, and end user. 

**Mastopexy Tissue Incision Insights**

On the basis of the tissue incision, the market is segmented into [skin](../../../reports/skin-cancer-market-1173), adipose, glandular, and others. 

### **Mastopexy Technique Insights**

On the basis of the technique, the market is categorised into anchor pattern, inverted-T incisions, lollipop pattern, and others. 

### **Mastopexy Application Insights**

On the basis of the application, the market is segmented into sagging [breast](../../../reports/global-breast-cancer-market-1379), augmented breast, and others. 

### **Mastopexy End-User Insights**

On the basis of end users, the market is segmented into hospitals & clinics, ambulatory surgery centres, and others.

### **Mastopexy Regional Insights**

The Americas dominates the mastopexy market owing to increasing adoption of new technologies, and developed healthcare sector. Moreover, rising healthcare expenditure and growing female geriatric population within the region boosts the market growth. Additionally, the presence of the developed economies and major market players within the region fuels the market growth.

Europe is the second largest Mastopexy Market owing to rising per capita healthcare sector and increasing demands for aesthetics. On regional basis, Europe is divided into Western Europe and Eastern Europe. Western Europe leads the regional mastopexy market due to the presence of developed economies like France, Germany, and Italy. On the other hand, Eastern Europe is estimated to be the fastest growing region within Europe.

Asia Pacific region is the fastest growing Mastopexy Market. Increasing awareness for women health, growing healthcare sector, and changing lifestyle are the major drivers for the market growth within the region. Moreover, the presence of the economies like Australia and China, which are marked by increasing number of cosmetic procedures within the Asia Pacific region, fuels the market growth. According to the International Society of Plastic Surgery in 2016, approximately 225,002 cosmetic procedures were performed in Australia.

The Middle East & Africa has the least share in the mastopexy market due to presence of poor economies and stringent government policies, especially in the African region. Majority of the market of the Middle East & Africa is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the presence of the economies like Saudi Arabia, Kuwait and Qatar within the region.

**Key players for mastopexy market**

**Intended Audience**

## Market Drivers

### Influence of Aging Population

The Mastopexy Market is significantly influenced by the aging population, as many women seek surgical options to address the physical changes associated with aging. As individuals age, factors such as gravity, hormonal changes, and lifestyle choices can lead to breast sagging, prompting a desire for mastopexy procedures. Current demographic trends indicate that the population aged 50 and above is growing, which may lead to an increased demand for breast lift surgeries. This demographic shift suggests that the Mastopexy Market could see a substantial rise in clientele, as older women seek to enhance their appearance and regain confidence.

### Advancements in Surgical Techniques

Technological innovations are playing a pivotal role in the Mastopexy Market, enhancing the safety and efficacy of breast lift procedures. Recent advancements, such as the introduction of 3D imaging and minimally invasive techniques, have improved surgical outcomes and reduced recovery times. For instance, the use of endoscopic techniques allows for smaller incisions and less scarring, which appeals to patients seeking less invasive options. As these technologies become more widely adopted, the Mastopexy Market is likely to experience increased patient satisfaction and a subsequent rise in demand for procedures.

### Rising Acceptance of Cosmetic Surgery

The Mastopexy Market is witnessing a shift in societal attitudes towards cosmetic surgery, with an increasing number of individuals openly discussing and considering such procedures. This acceptance is fueled by the proliferation of social media platforms, where influencers and celebrities often share their experiences with aesthetic enhancements. Data suggests that nearly 70% of individuals aged 18-34 view cosmetic surgery positively, indicating a generational shift in perception. As this trend continues, the Mastopexy Market may see a broader demographic engaging in mastopexy procedures, thereby expanding its customer base and driving market growth.

### Increasing Demand for Aesthetic Procedures

The Mastopexy Market is experiencing a notable surge in demand for aesthetic procedures, driven by a growing societal emphasis on physical appearance. This trend is particularly evident among women seeking breast enhancement and rejuvenation. According to recent data, the aesthetic surgery sector has seen a consistent annual growth rate of approximately 5% over the past few years. This increase is attributed to factors such as rising disposable incomes, greater access to cosmetic surgery, and a cultural shift towards self-improvement. As more individuals prioritize their appearance, the Mastopexy Market is likely to benefit from this heightened interest, leading to an expansion in service offerings and innovations in surgical techniques.

### Growing Focus on Women's Health and Wellness

The Mastopexy Market is benefiting from an increased focus on women's health and wellness, which encompasses not only physical health but also mental and emotional well-being. As women become more empowered to make choices about their bodies, there is a corresponding rise in interest in procedures like mastopexy. This trend is supported by various health campaigns promoting body positivity and self-care. Data indicates that women are increasingly prioritizing their health and appearance, leading to a projected growth rate of 6% in the mastopexy segment over the next five years. This focus on holistic wellness is likely to further drive the Mastopexy Market.

## Future Outlook

The Mastopexy Market is projected to grow at a 5.22% CAGR from 2025 to 2035, driven by increasing aesthetic awareness, technological advancements, and rising disposable incomes.

**New opportunities:**

- Expansion of [telemedicine](https://www.marketresearchfuture.com/reports/telemedicine-market-2216) consultations for pre- and post-operative care. Development of minimally invasive mastopexy techniques to attract more patients. Partnerships with wellness centers to offer comprehensive aesthetic packages.

By 2035, the Mastopexy Market is expected to achieve robust growth, reflecting evolving consumer preferences.

## Segment Insights

### By Tissue Incision: Skin (Largest) vs. Adipose (Fastest-Growing)

In the Mastopexy Market, the tissue incision segment is divided into four primary categories: skin, adipose, glandular, and others. Currently, the skin tissue is the largest segment, dominating the market due to its critical role in conventional mastopexy procedures, contributing significantly to mastopexy market share. This category has a commanding presence because it directly correlates with the aesthetic outcomes that patients desire, leading to its widespread adoption. Conversely, the adipose tissue segment is emerging rapidly, spurred by advancements in techniques that prioritize fat grafting and minimal invasiveness, making it increasingly appealing for both patients and surgeons alike. The growth trends within the tissue incision segment are significantly influenced by technological advancements and evolving surgical techniques. Specifically, innovations in adipose tissue applications are surpassing traditional methods, creating a shift in preference towards more adaptive and patient-centered approaches. Factors such as an increased focus on safety, recovery time, and natural-looking results are driving the adoption of adipose incision techniques. As patient preferences evolve, the market is expected to reflect these changes, with adipose tissue rapidly gaining traction among cosmetic surgeons striving to offer cutting-edge procedures that enhance patient satisfaction.

Skin (Dominant) vs. Adipose (Emerging)

The skin tissue segment stands as the dominant choice in the Mastopexy Market due to its pivotal importance in accomplishing satisfactory aesthetic results. Surgeons utilize skilled incision techniques to optimize skin elasticity and shape, significantly affecting surgical outcomes. However, the adipose tissue segment is recognized as an emerging player, gaining popularity thanks to innovations such as Fat Transfer techniques. This approach leverages the body's natural fat to restore volume and achieve desired contours without the drawbacks associated with synthetic implants. Although still growing, the adoption of adipose techniques is fueled by patients' desire for body harmony and a less invasive recovery process. As surgeon familiarity with this technique increases, it is poised to capture a larger share of the market.

### By Technique: Anchor Pattern (Largest) vs. Lollipop Pattern (Fastest-Growing)

The Mastopexy Market showcases a diverse range of techniques, each fulfilling specific patient requirements. Among these, the anchor pattern technique remains the largest segment, favored for its ability to produce substantial lift and contour. The inverted-T incisions and lollipop patterns also hold significant shares, responding to varying patient anatomy and desired aesthetic outcomes. Meanwhile, the 'others' category includes innovative techniques that are slowly carving a niche in the market. As trends evolve, the lollipop pattern has emerged as the fastest-growing technique due to its less invasive nature, offering a balance between efficiency and aesthetic results. With an increasing number of professionals opting for this method, driven by lower scarring and recovery times, the overall landscape of the mastopexy market reflects a shift towards patient-preferred techniques that promise better outcomes and satisfaction.

Technique: Anchor Pattern (Dominant) vs. Lollipop Pattern (Emerging)

The anchor pattern technique stands out as the dominant choice in the mastopexy market, renowned for its effectiveness in achieving dramatic breast elevation and shaping. This method allows extensive tissue manipulation, making it suitable for patients requiring significant lift. On the other hand, the lollipop pattern is emerging rapidly as a preferred technique among younger patients due to its appealing compromise between aesthetic results and minimally invasive approach. While the anchor pattern delivers tried-and-true results, the lollipop pattern's rise is fueled by its promise of reduced downtime and minimal scarring compared to traditional methods. As aesthetic preferences change towards less invasive options, both techniques continue to evolve, catering to diverse patient demands.

### By Application: Sagging Breast (Largest) vs. Augmented Breast (Fastest-Growing)

In the Mastopexy Market, the application segment is primarily divided between sagging breast procedures, augmented breast surgeries, and other applications. Sagging breasts account for a significant portion of the market share due to the increasing geriatric population and rising awareness about aesthetic procedures among middle-aged women. Augmented breast procedures are also gaining traction, fueled by trends in body positivity and the desire for enhanced aesthetics, making them a competitive segment within the market.

Sagging Breast (Dominant) vs. Augmented Breast (Emerging)

The sagging breast segment is characterized by demand driven by the natural aging process and lifestyle changes that affect breast elasticity. With a more substantial market presence, this segment is recognized for its role in enhancing physical appearance and boosting confidence among women. Conversely, the augmented breast segment, while emerging, shows rapid growth due to evolving beauty standards and advancements in breast implant technology. Women across various demographics are increasingly opting for breast augmentation, contributing to its status as the fastest-growing segment in the Mastopexy Market. These two segments reflect distinct yet overlapping desires within the consumer base.

### By End User: Hospitals & Clinics (Largest) vs. Ambulatory Surgery Centres (Fastest-Growing)

The Mastopexy Market is significantly shaped by its end user segments, primarily comprising hospitals and clinics, along with [ambulatory surgery centers](https://www.marketresearchfuture.com/reports/ambulatory-surgery-centers-market) and others. Hospitals and clinics represent the largest share due to their capacity to provide comprehensive surgical services and post-operative care. Their established infrastructure and reputation for patient safety make them the preferred choice for various surgical procedures, including mastopexy. In contrast, ambulatory surgery centers are emerging as a popular alternative, attracting a growing number of patients seeking minimally invasive surgeries and shorter recovery times, thus expanding their footprint in the market.

Hospitals & Clinics (Dominant) vs. Ambulatory Surgery Centres (Emerging)

Hospitals and clinics dominate the Mastopexy Market primarily due to their extensive resources, skilled personnel, and ability to manage complex surgical procedures. They offer a wide range of surgical options and have established patient relationships, contributing to their significant market presence. In contrast, ambulatory surgery centers are gaining momentum as they specialize in outpatient surgeries, allowing for quicker procedures, reduced costs, and increased patient convenience. This shift towards outpatient care is driven by patients' growing preference for avoiding long hospital stays, thereby benefiting from lower infection risks and streamlined processes. As such, ambulatory surgery centers are poised for rapid growth within the Mastopexy Market.

## Regional Market Share Analysis

### North America : Market Leader in Aesthetic Surgery

North America is the largest market for mastopexy, accounting for approximately 45% of the global share. The region's growth is driven by increasing consumer awareness, advancements in surgical techniques, and a rising trend towards aesthetic procedures. Regulatory support from bodies like the FDA has also catalyzed market expansion, ensuring safety and efficacy in surgical practices. The demand for breast lift surgeries is further fueled by the aging population seeking aesthetic enhancements. The United States is the leading country in this market, with a significant presence of key players such as Allergan, Mentor Worldwide, and Sientra. The competitive landscape is characterized by continuous innovation and marketing strategies aimed at educating consumers about the benefits of mastopexy. Canada follows as the second-largest market, contributing to the overall growth with a focus on minimally invasive techniques and patient safety.

### Europe : Emerging Market with Growth Potential

Europe is witnessing a growing demand for mastopexy, holding approximately 30% of the global market share. Factors such as increasing disposable income, changing beauty standards, and a rise in cosmetic tourism are driving this growth. Countries like Germany and France are at the forefront, supported by favorable regulations and a robust healthcare infrastructure. The European market is also influenced by the increasing acceptance of aesthetic procedures among younger demographics, further propelling demand. Germany leads the European market, followed closely by France and the UK. The competitive landscape is marked by the presence of established players like Galderma and Ipsen, alongside emerging companies. Regulatory bodies such as the European Medicines Agency (EMA) ensure that products meet safety standards, fostering consumer trust and encouraging market growth. The focus on innovation and quality in surgical procedures is expected to enhance the market further.

### Asia-Pacific : Rapidly Growing Aesthetic Market

Asia-Pacific is rapidly emerging as a significant player in the mastopexy market, accounting for approximately 20% of the global share. The region's growth is fueled by increasing disposable incomes, a growing middle class, and a cultural shift towards aesthetic enhancements. Countries like South Korea and Japan are leading this trend, supported by advancements in technology and a rise in medical tourism. Regulatory frameworks are evolving to accommodate the growing demand for cosmetic procedures, ensuring safety and efficacy. South Korea is at the forefront of the mastopexy market, known for its innovative surgical techniques and high-quality standards. The competitive landscape features key players like Hugel and Medytox, who are actively expanding their product offerings. Japan follows closely, with a strong emphasis on patient safety and satisfaction. The increasing acceptance of cosmetic procedures among younger populations is expected to drive further growth in this region.

### Middle East and Africa : Emerging Market with Unique Challenges

The Middle East and Africa region is gradually emerging in the mastopexy market, holding about 5% of the global share. The growth is driven by increasing awareness of aesthetic procedures, rising disposable incomes, and a growing trend towards cosmetic enhancements. Countries like the UAE and South Africa are leading this growth, supported by a burgeoning medical tourism sector. However, regulatory challenges and varying cultural perceptions of cosmetic surgery present unique hurdles for market expansion. The UAE is the leading market in this region, known for its luxury healthcare services and high demand for aesthetic procedures. South Africa follows, with a focus on enhancing patient safety and quality of care. The competitive landscape includes both local and international players, with a growing emphasis on innovative techniques and patient education. As awareness continues to rise, the market is expected to expand further, albeit at a slower pace compared to other regions.

## Competitive Benchmarking

The Mastopexy Market is currently characterized by a dynamic competitive landscape, driven by increasing consumer demand for aesthetic procedures and advancements in surgical techniques. Key players such as Allergan (US), Mentor Worldwide (US), and Galderma (CH) are strategically positioned to leverage their extensive product portfolios and innovative technologies. Allergan (US) focuses on enhancing its offerings through continuous research and development, while Mentor Worldwide (US) emphasizes its commitment to safety and efficacy in breast surgery products. Galderma (CH), on the other hand, is expanding its reach through strategic partnerships and collaborations, thereby enhancing its market presence. Collectively, these strategies contribute to a competitive environment that is increasingly focused on innovation and customer-centric solutions.
In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The Mastopexy Market appears to be moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and services, catering to different consumer preferences and regional demands. The collective influence of these key players shapes the market structure, fostering an environment where innovation and quality are paramount.
In August 2025, Allergan (US) announced the launch of a new line of breast implants designed with advanced materials aimed at improving patient outcomes. This strategic move not only reinforces Allergan's commitment to innovation but also positions the company to capture a larger share of the market by addressing evolving consumer preferences for safety and performance. The introduction of these implants is likely to enhance brand loyalty and attract new customers seeking cutting-edge solutions.
In September 2025, Mentor Worldwide (US) entered into a partnership with a leading technology firm to develop AI-driven tools for surgical planning and patient education. This collaboration signifies a shift towards integrating technology into surgical practices, potentially improving surgical outcomes and patient satisfaction. By leveraging AI, Mentor Worldwide (US) aims to differentiate itself in a competitive market, enhancing its value proposition to both surgeons and patients.
In July 2025, Galderma (CH) expanded its product line by acquiring a smaller company specializing in regenerative medicine. This acquisition is indicative of Galderma's strategy to diversify its offerings and tap into the growing demand for non-surgical aesthetic procedures. By integrating regenerative technologies, Galderma (CH) is likely to enhance its competitive edge and appeal to a broader customer base seeking innovative solutions.
As of October 2025, the Mastopexy Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence into surgical practices. These trends are reshaping the competitive landscape, with companies increasingly forming strategic alliances to enhance their capabilities and market reach. The shift from price-based competition to a focus on innovation, technology, and supply chain reliability is becoming evident. Moving forward, competitive differentiation will likely hinge on the ability to deliver superior products and services that align with evolving consumer expectations.

## Report Scope

| MARKET SIZE 2024 | 1.263(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 1.329(USD Billion) |
| MARKET SIZE 2035 | 2.21(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.22% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Allergan (US), Mentor Worldwide (US), Sientra (US), Galderma (CH), Hugel (KR), Ipsen (FR), Revance Therapeutics (US), Medytox (KR) |
| Segments Covered | Tissue Incision |
| Key Market Opportunities | Emergence of minimally invasive techniques enhances patient appeal in the Mastopexy Market. |
| Key Market Dynamics | Rising consumer demand for aesthetic procedures drives innovation and competition in the mastopexy market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Mastopexy Market as of 2024?**
A: The Mastopexy Market was valued at 1.263 USD Billion in 2024.

**Q: What is the projected market size for the Mastopexy Market in 2035?**
A: The Mastopexy Market is projected to reach 2.21 USD Billion by 2035.

**Q: What is the expected CAGR for the Mastopexy Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Mastopexy Market during 2025 - 2035 is 5.22%.

**Q: Which companies are considered key players in the Mastopexy Market?**
A: Key players in the Mastopexy Market include Allergan, Mentor Worldwide, Sientra, Galderma, Hugel, Ipsen, Revance Therapeutics, and Medytox.

**Q: What are the main segments of the Mastopexy Market?**
A: The main segments of the Mastopexy Market include Tissue Incision, Technique, Application, and End User.

**Q: What was the valuation of the Tissue Incision segment in 2024?**
A: The Tissue Incision segment was valued at 1.008 USD Billion in 2024.

**Q: How does the Application segment perform in the Mastopexy Market?**
A: The Application segment, particularly for sagging breasts, was valued at 0.635 USD Billion in 2024.

**Q: What is the projected valuation for the End User segment by 2035?**
A: The End User segment is projected to reach 1.12 USD Billion by 2035.

**Q: Which technique is expected to dominate the Mastopexy Market?**
A: The anchor pattern and inverted-T incisions techniques are expected to dominate, each valued at 0.379 USD Billion in 2024.

**Q: What is the significance of ambulatory surgery centers in the Mastopexy Market?**
A: Ambulatory surgery centers were valued at 0.378 USD Billion in 2024, indicating their growing importance in the market.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/mastopexy-market-5323*